GlassScriptPhysician profile
John K Riles
NPI 1629116850
$689.13
in general payments reported to CMS, 2019-2025
9 companies · $393 in 2025
The $393 reported for 2025 was more than what 76% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.02 · 2022: $35.62 · 2024: $170 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $213.80 | 2025 | Barricaid Acd (Annular Closure Device) |
| Stryker Corporation | $182.49 | 2022-2025 | Mako |
| Heron Therapeutics, INC. | $141.52 | 2024 | Zynrelef |
| Horizon Therapeutics Plc | $72.82 | 2021-2022 | |
| Si-Bone, INC. | $28.51 | 2024 | |
| Ferring Pharmaceuticals INC. | $21.41 | 2021 | |
| Nalu Medical, INC. | $13.88 | 2025 | Nalu Neurostimulation System |
| Radius Health, INC. | $12.96 | 2021 | |
| Electronic Waveform Lab, INC. | $1.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Riles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.